Skip to content
★ Sign in to follow
이

이병기

신신제약
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 10 Feb 2026 for 신신제약.

이병기: trading record in brief

This profile gathers the share dealings of 이병기 in 신신제약. We count 6 filings; the first trade dates from 23 December 2022 and the latest from 6 February 2026.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 10 February 2026 with a transaction in 신신제약. The median gap between a trade and its publication by DART (FSS) is 5 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Companies and markets linked to 이병기

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations